newsfilter
← Latest News
PR Newswire·

Amgen Completes Acquisition Of Otezla® (apremilast)

Amgen (NASDAQ:AMGN) today announced the successful completion of its acquisition of worldwide rights to Otezla® (apremilast), the only oral,...